On ECHEMI
Home > Drugs > Spindle cell hemangioendothelioma
Spindle cell hemangioendothelioma
Spindle cell hemangioendothelioma was first reported by Weiss and Enzinger in 1986. This disease is a non-neoplastic, reactive vascular proliferation accompanied by vascular malformation and periodic vascular recanalization after thrombosis.
  • Site of disease:

    Blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Microthrombosis Subcutaneous nodules Vascular malformations Angiogenesis Edema
  • Concurrent disease:

Related Drugs
Yunzhi intracellular glycopeptide capsules
Indication: Used as an adjuvant treatment for chronic hepatitis B, liver cancer and the elderly with impaired immune function.
Manufacturer:

Shandong Huaxin Pharmaceutical Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.